Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia

This study has been completed.
Information provided by (Responsible Party):
Apceth GmbH & Co. KG Identifier:
First received: May 10, 2011
Last updated: December 14, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)